FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Tailstorm Health LIDOcaine HCL Sterile Injection Recall

LIDOcaine HCL Sterile Injection, USP, 20 mg/mL, 2%, (200 mg/10 mL), For Infiltration &…

Tailstorm Health INC · Phoenix, AZ

Risk level
Class II
Reported by FDA
Jul 9, 2025
Recall ID
D-0503-2025
Check your lot numberHow we source this data

Summary

Tailstorm Health recalled LIDOcaine HCL Sterile Injection starting Jun 2, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0503-2025 on Jul 9, 2025. Reason: Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process. Status: Ongoing.

Why it was recalled

Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.

Product description

LIDOcaine HCL Sterile Injection, USP, 20 mg/mL, 2%, (200 mg/10 mL), For Infiltration & Nerve Block, Including Caudal & Epidural Use, Preservative Free, 10mL Sterile Single-Dose Vial, Rx Only, Medivant Healthcare, 158 S. Kyrene Rd., Chandler, AZ, 85226, NDC 81483-0001-0.

Lot numbers, UPCs & expiration codes

Lot #: 2504003, Exp. 04/03/2027

Where it was sold

Nationwide in the US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0503-2025
Classification
Class II
Status
Ongoing
Recall initiated
Jun 2, 2025
FDA report date
Jul 9, 2025
Quantity
4875 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Tailstorm Health INC

Original FDA data

Every field from FDA enforcement report D-0503-2025, exactly as published.

Show all FDA fields
City
Phoenix
State
AZ
Status
Ongoing
Country
United States
Event ID
96996
Address
24416 N 19th Ave Ste 200
Code information
Lot #: 2504003, Exp. 04/03/2027
Postal code
85085-1400
Report date
Jul 9, 2025
Product type
Drugs
Recall number
D-0503-2025
Classification
Class II
Recalling firm
Tailstorm Health INC
Product quantity
4875 vials
Reason for recall
Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
Voluntary / mandated
Voluntary: Firm initiated
Product description
LIDOcaine HCL Sterile Injection, USP, 20 mg/mL, 2%, (200 mg/10 mL), For Infiltration & Nerve Block, Including Caudal & Epidural Use, Preservative Free, 10mL Sterile Single-Dose Vial, Rx Only, Medivant Healthcare, 158 S. Kyrene Rd., Chandler, AZ, 85226, NDC 81483-0001-0.
Distribution pattern
Nationwide in the US
Recall initiation date
Jun 2, 2025
Center classification date
Jun 30, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0503-2025, published Jul 9, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls